We hypothesized that overexpression of specific glutamate receptors within the hippocampus would induce seizures and the associated cellular changes seen in temporal lobe epilepsy (TLE). The GluR6 kainate receptor was overexpressed by injecting rat hippocampi with HSVGluR6, a viral vector transducing fully edited GluR6. These animals experienced limbic seizures approximately 4 h following the injection. Control animals injected with HSVlac, a vector expressing ␤-galactosidase, did not have seizures. Recordings from hippocampal CA1 pyramidal cells were performed 12 to 48 h and 1 week to 1 month postinjection. We observed nonsynaptic Na ؉ -mediated bursting in 77.5% of cells 12 to 48 h following injection of HSVGluR6 but not HSVlac. The synaptic responses were normal in both groups. However, the physiological properties of cells from HSVGluR6-injected hippocampi changed over time. Two weeks following HSVGluR6 injection, synaptic bursts could be evoked, but intrinsic bursting became rare. These changes persisted for at least 1 month. We postulate that this transition from intrinsic to synaptic hyperexcitability may be important in the development of TLE.
INTRODUCTION
Medial temporal lobe sclerosis (MTS) is a stereotyped pathology associated with medically intractable seizures. MTS is characterized by a pattern of severe cell loss in the CA1 and CA3 pyramidal cell populations of the hippocampus as well as in the dentate hilus; in addition there is extensive synaptic reorganization of both excitatory and inhibitory fiber systems (see de Lanerolle et al., 1992 , for a review). An intriguing feature of MTS is that there is often an early childhood insult (e.g., high fever, trauma, or cortical infection) associated with seizures followed by a variable latent period (Mathern et al., 1996) . Because of the stereotyped pathology and the intractability of this type of seizure disorder, MTS has been a major focus of epilepsy research.
One commonly used model of MTS involves injection of the glutamate receptor agonist, kainic acid (KA) into rats. Intracerebral or systemic injection of KA leads to a pathology similar to that seen in MTS (Ben-Ari et al., 1985; Tauck et al., 1985; Buckmaster & Dudek, 1999) and there is a latent period before the onset of recurrent seizures (e.g., Hellier et al., 1998) . Physiological changes seen in both CA1 pyramidal cells and dentate granule cells have been extensively studied by several groups (Esclapez et al., 1999; Bragnin et al., 1999; Perez et al., 1996) and resemble those seen in human patients (Williamson, 1994) . However, one obvious problem with using the KA model as an
